Susceptibility to innate immune activation in genetically mediated myocarditis
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Myocarditis is clinically characterized by chest pain, arrhythmias, and heart failure, and treatment is often supportive. Mutations in DSP , a gene encoding the desmosomal protein desmoplakin, have been increasingly implicated in myocarditis. To model DSP -associated myocarditis and assess the role of innate immunity, we generated engineered heart tissues (EHTs) using human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) from patients with heterozygous DSP truncating variants ( DSP tvs) and a gene-edited homozygous deletion cell line ( DSP –/– ). At baseline, DSP –/– EHTs displayed a transcriptomic signature of innate immune activation, which was mirrored by cytokine release. Importantly, DSP –/– EHTs were hypersensitive to Toll-like receptor (TLR) stimulation, demonstrating more contractile dysfunction compared with isogenic controls. Relative to DSP –/– EHTs, heterozygous DSP tv EHTs had less functional impairment. DSP tv EHTs displayed heightened sensitivity to TLR stimulation, and when subjected to strain, DSP tv EHTs developed functional deficits, indicating reduced contractile reserve compared with healthy controls. Colchicine or NF-κB inhibitors improved strain-induced force deficits in DSP tv EHTs. Genomic correction of DSP p.R1951X using adenine base editing reduced inflammatory biomarker release from EHTs. Thus, EHTs replicate electrical and contractile phenotypes seen in human myocarditis, implicating cytokine release as a key part of the myogenic susceptibility to inflammation. The heightened innate immune activation and sensitivity are targets for clinical intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Of monumental importance, genetic correction of DSP p.R1951X was accompanied by a substantial reduction in NFκB mRNA expression, further suggesting that the mere presence of a desmosomal gene variant drives myocardial inflammation rather than being a consequence of infiltrating immune cells.”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [70]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At baseline, DSP−/− EHTs exhibit a transcriptomic signature of innate immune activation, mirrored by elevated concentrations of multiple cytokines, including IL-1β, IL-6, IL-8, IFN-γ, IL-17, and IL-23, which were detected in the EHT cell culture media; thus, they are of cardiomyocyte origin rather than from immune cells [70].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [70]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DSP-linked ACM is strongly associated with a myocardial fibro-inflammatory phenotype and a higher frequency of episodic “hot phases,” typically manifesting in the left ventricle and frequently observed via LGE-MRI [52,70].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [70]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Anti-inflammatory strategies, including colchicine, a broad anti-inflammatory agent, or NFκB inhibitors, effectively rescue these force deficits.”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [70]
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, heterozygous DSP-tv EHTs exhibited only minimal baseline contractile deficits, though they exhibited elevated innate immune activation relative to healthy controls, reflected by increased IL-1β secretion into cell culture media upon Toll-like receptor (TLR) stimulation via exogenous application of HMGB1.”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A. H., Tanaseichuk, O., Benner, C., & Chanda, S. K. (2019) · Nature Communications · doi:10.1038/s41467-019-09234-6 · Cited by 14,611
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens
Concordet, J.-P., & Haeussler, M. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky354 · Cited by 2,655 · cited 1×
“DSP –/– cells were generated using gRNAs designed by CRISPOR (66), which targeted DSP exon 24 (Supplemental Table 7). gRNAs 190 and 202 were placed into the Cas9-expressing pSpCas9(BB)-2A-Puro (PX459) V2.”
MethodEasy quantitative assessment of genome editing by sequence trace decomposition
Brinkman, E. K., Chen, T., Amendola, M., & van Steensel, B. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku936 · Cited by 2,390 · cited 1×
“After 10 days, colonies were isolated and then screened by Sanger sequencing and TIDE analysis (67).”
MethodChemically defined generation of human cardiomyocytes
Burridge, P. W., Matsa, E., Shukla, P., Lin, Z. C., Churko, J. M., Ebert, A. D., Lan, F., Diecke, S., Huber, B., Mordwinkin, N. M., et al. (2014) · Nature Methods · doi:10.1038/nmeth.2999 · Cited by 1,606 · cited 1×
“Cells were passaged once every 4–5 days at 80%–90% confluence by washing with 1× PBS and incubating with ReLeSR (STEMCELL Technologies, catalog 100-0483) for 3 minutes at 37°C. hiPSC-CMs were differentiated using small molecule modulation of the Wnt signaling pathway (64).”
MethodSelf-citationCardioimmunology: the immune system in cardiac homeostasis and disease
Swirski, F. K., & Nahrendorf, M. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0065-8 · Cited by 849 · cited 1×
“Importantly, paracrine signaling from cardiomyocytes can amplify inflammation through local effects and by recruiting leukocytes to the myocardium, further intensifying mechanical defects (60, 61).”
BackgroundArrhythmogenic Right Ventricular Cardiomyopathy
Corrado, D., Link, M. S., & Calkins, H. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1509267 · Cited by 736
Mechanically activated ion channel Piezo1 modulates macrophage polarization and stiffness sensing
Atcha, H., Jairaman, A., Holt, J. R., Meli, V. S., Nagalla, R. R., Veerasubramanian, P. K., Brumm, K. T., Lim, H. E., Othy, S., Cahalan, M. D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23482-5 · Cited by 644 · cited 1×
“In macrophages, PIEZO1 is required for inflammatory signaling, so it is possible that similar pathways are activated with desmosomal disruption in cardiomyocytes and skin (58, 59).”
BackgroundGiacomelli, E., Meraviglia, V., Campostrini, G., Cochrane, A., Cao, X., van Helden, R. W. J., Krotenberg Garcia, A., Mircea, M., Kostidis, S., Davis, R. P., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.05.004 · Cited by 622 · cited 1×
“Compared with hiPSC-CMs grown in monolayers in the dish, an advantage of bioengineered platforms like EHTs is the alignment of cardiomyocytes, which promotes the formation of intercellular junctions (37, 38).”
BackgroundEditR: A Method to Quantify Base Editing from Sanger Sequencing
Kluesner, M. G., Nedveck, D. A., Lahr, W. S., Garbe, J. R., Abrahante, J. E., Webber, B. R., & Moriarity, B. S. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0014 · Cited by 565 · cited 1×
“Editing efficiency was estimated using with EditR (69) to analyze chromatograms resulting from Sanger sequencing.”
MethodSmith, E. D., Lakdawala, N. K., Papoutsidakis, N., Aubert, G., Mazzanti, A., McCanta, A. C., Agarwal, P. P., Arscott, P., Dellefave-Castillo, L. M., Vorovich, E. E., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044934 · Cited by 504 · cited 9×
“Desmosomal gene mutations are best known for their role in arrhythmogenic right ventricular cardiomyopathy (ARVC) (7).”
BackgroundInfluentialSelf-citationGroeneweg, J. A., Bhonsale, A., James, C. A., te Riele, A. S., Dooijes, D., Tichnell, C., Murray, B., Wiesfeld, A. C. P., Sawant, A. C., Kassamali, B., et al. (2015) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.114.001003 · Cited by 491 · cited 1×
“In ARVC, the des-mosomal gene plakophilin 2 ( PKP2 ) is the dominant ARVC-as-sociated gene, with other desmosomal genes being much less represented (8).”
BackgroundDeterminants of Base Editing Outcomes from Target Library Analysis and Machine Learning
Arbab, M., Shen, M. W., Mok, B., Wilson, C., Matuszek, Ż., Cassa, C. A., & Liu, D. R. (2020) · Cell · doi:10.1016/j.cell.2020.05.037 · Cited by 294 · cited 1×
“For base-editing correction of DSP c.5851 C > T p.R1951X hiPSC line, gRNAs were designed using BE Hive (68). gRNAs 6, 7, and 8 were ligated into pmCherry_gRNA plasmid (Addgene plasmid 8045) vector.”
MethodBasso, C. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2114478 · Cited by 225
Gomes, J., Finlay, M., Ahmed, A. K., Ciaccio, E. J., Asimaki, A., Saffitz, J. E., Quarta, G., Nobles, M., Syrris, P., Chaubey, S., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr472 · Cited by 194 · cited 2×
“Reduction of DSP expression and DSP mutations are associated with reduced membrane targeting of connexin-43 (Cx43, GJA1 ) (25, 26).”
BackgroundTherapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy
Chelko, S. P., Asimaki, A., Lowenthal, J., Bueno-Beti, C., Bedja, D., Scalco, A., Amat-Alarcon, N., Andersen, P., Judge, D. P., Tung, L., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.040676 · Cited by 192 · cited 4×
“In humans, heterozygous PKP2 and DSG2 mutations lead to ARVC, but in mice, homozygous deletion of Dsg2 and Pkp2 in the mouse heart is required to elicit cardiomyopathy and to define NF-κ B activation, since heterozygous deletion has little phenotype in mice (27–30).”
BackgroundMethodInfluentialHuman engineered heart tissue as a model system for drug testing
Eder, A., Vollert, I., Hansen, A., & Eschenhagen, T. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.010 · Cited by 190 · cited 2×
“EHTs are generated by mixing hiPSC-CMs with healthy cardiac fibroblasts at a 9:1 ratio (CMs/cardiac fibroblast) into a fibrin or collagen matrix, then maturing for at least 20 days (35, 36).”
BackgroundMethodGenetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy
Lota, A. S., Hazebroek, M. R., Theotokis, P., Wassall, R., Salmi, S., Halliday, B. P., Tayal, U., Verdonschot, J., Meena, D., Owen, R., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.058457 · Cited by 184 · cited 2×
“Although additional cardiomyopathy gene mutations have been described in these myocarditis case series, DSP is the most common gene reported, especially among those with relatively intact left ventricular function (4).”
BackgroundFlorian, S., & Mitchison, T. J. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-3542-0_25 · Cited by 171 · cited 1×
“We also sought to understand the role of microtubules in mediating antiinflammatory therapy by treating DSP p.R1951X EHTs with BAY 11-7082, colchicine, and nocodazole, a microtubule inhibitor that is not known to have antiinflammatory effects (49, 50).”
BackgroundDeftereos, S., Giannopoulos, G., Papoutsidakis, N., Panagopoulou, V., Kossyvakis, C., Raisakis, K., Cleman, M. W., & Stefanadis, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.726 · Cited by 161 · cited 1×
“The patient with the DSP p.E1597X truncation variant was treated with colchicine, with improvement of symptoms since colchicine has been used to treat a broad array of cardiovascular conditions associated with inflammation (48).”
MethodOridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity
Li, X., Zhang, C., Ma, W., Xie, X., & Huang, Q. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.645824 · Cited by 160 · cited 1×
“We also tested oridonin because it inhibits the NLRP3 inflammasome, a protein complex implicated in innate immune activation (47).”
Method‘Hot phase’ clinical presentation in arrhythmogenic cardiomyopathy
Bariani, R., Cipriani, A., Rizzo, S., Celeghin, R., Bueno Marinas, M., Giorgi, B., De Gaspari, M., Rigato, I., Leoni, L., Zorzi, A., et al. (2021) · EP Europace · doi:10.1093/europace/euaa343 · Cited by 154 · cited 1×
“With additional stimuli, the concealed phase can transition to a “hot phase” of myocarditis, characterized by inflammation and accompanying arrhythmias (9, 53, 54).”
BackgroundAcute Myocarditis Associated With Desmosomal Gene Variants
Ammirati, E., Raimondi, F., Piriou, N., Sardo Infirri, L., Mohiddin, S. A., Mazzanti, A., Shenoy, C., Cavallari, U. A., Imazio, M., Aquaro, G. D., et al. (2022) · JACC: Heart Failure · doi:10.1016/j.jchf.2022.06.013 · Cited by 150 · cited 2×
“Clinically, myocarditis often comes on acutely, and it has both genetic and environmental triggers, including viral infections or response to vaccination (2).”
BackgroundBliley, J. M., Vermeer, M. C. S. C., Duffy, R. M., Batalov, I., Kramer, D., Tashman, J. W., Shiwarski, D. J., Lee, A., Teplenin, A. S., Volkers, L., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd1817 · Cited by 134 · cited 2×
“Bliley and colleagues demonstrated altered contractility in patient-derived DSP EHTs under conditions of diastolic lengthening that increased desmosomal gene and protein expression (39).”
BackgroundInflammation and Immune Response in Arrhythmogenic Cardiomyopathy: State-of-the-Art Review
Asatryan, B., Asimaki, A., Landstrom, A. P., Khanji, M. Y., Odening, K. E., Cooper, L. T., Marchlinski, F. E., Gelzer, A. R., Semsarian, C., Reichlin, T., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.055890 · Cited by 120 · cited 6×
“Desmosomal gene mutations are best known for their role in arrhythmogenic right ventricular cardiomyopathy (ARVC) (7).”
BackgroundInfluentialKumar, A., Negi, G., & Sharma, S. S. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01402.x · Cited by 118 · cited 1×
“We also tested JSH-23, an inhibitor of NF-κ B transcriptional activity (46).”
MethodPlakophilin-2 loss promotes TGF-β1/p38 MAPK-dependent fibrotic gene expression in cardiomyocytes
Dubash, A. D., Kam, C. Y., Aguado, B. A., Patel, D. M., Delmar, M., Shea, L. D., & Green, K. J. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201507018 · Cited by 113
Self-citationConnexin defects underlie arrhythmogenic right ventricular cardiomyopathy in a novel mouse model
Lyon, R. C., Mezzano, V., Wright, A. T., Pfeiffer, E., Chuang, J., Banares, K., Castaneda, A., Ouyang, K., Cui, L., Contu, R., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt508 · Cited by 111 · cited 1×
“Additional clinical studies are needed to evaluate the efficacy of colchicine for genetically mediated myocarditis.”
BackgroundSuetomi, T., Miyamoto, S., & Brown, J. H. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00223.2019 · Cited by 108 · cited 1×
“Importantly, paracrine signaling from cardiomyocytes can amplify inflammation through local effects and by recruiting leukocytes to the myocardium, further intensifying mechanical defects (60, 61).”
BackgroundDesmosomes: Essential contributors to an integrated intercellular junction network
Green, K. J., Jaiganesh, A., & Broussard, J. A. (2019) · F1000Research · doi:10.12688/f1000research.20942.1 · Cited by 103 · cited 2×
“In the absence of DSP , there is an activation of ERK1/2–MAPK stress signaling, which leads to increased phosphorylation of Cx43, subsequently triggering degradation of gap junctions via lysosomes (6).”
BackgroundSelf-citationGenetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression
Gacita, A. M., Fullenkamp, D. E., Ohiri, J. C., Pottinger, T. D., Puckelwartz, M. J., Nóbrega, M. A., & McNally, E. M. (2021) · Circulation · doi:10.1161/circulationaha.120.050432 · Cited by 103 · cited 2×
“…synthesized from isolated RNA using qScript cDNA SuperMix (QuantaBio) and used for downstream applications. qPCR analysis was performed as previously described (65) with the ∆∆ Ct method using the geometric mean expression of cardiomyocyte reference genes and primers listed in Supplemental Table 7.”
MethodSelf-citationStretching the Function of Innate Immune Cells
Orsini, E. M., Perelas, A., Southern, B. D., Grove, L. M., Olman, M. A., & Scheraga, R. G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.767319 · Cited by 92
Patel, D. M., Dubash, A. D., Kreitzer, G., & Green, K. J. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201312110 · Cited by 83
Self-citationPaller, A. S., Czarnowicki, T., Renert‐Yuval, Y., Holland, K. E., Huynh, T. N., Sadlier, M., McAleer, M. A., Tran, G., Geddes, G. C., Irvine, A. D., et al. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.10.026 · Cited by 81 · cited 7×
“We observed upregulation of Th17-dominant lymphocytic chemokines with increases in IL-17 and IL-23 (Figure 3, I and J).”
BackgroundInfluentialWu, S.-P., Kao, C.-Y., Wang, L., Creighton, C. J., Yang, J., Donti, T. R., Harmancey, R., Vasquez, H. G., Graham, B. H., Bellen, H. J., et al. (2015) · Nature Communications · doi:10.1038/ncomms9245 · Cited by 73 · cited 1×
“ZNF416 is a zinc finger nuclease associated with fibroblast activation (43), and COUPTFII, encoded by the gene NR2F2 , has been reported to repress glucocorticoid transcriptional activity and alter cardiac metabolism in heart failure (44).”
Piriou*, N., Marteau, L., Kyndt, F., Serfaty, J. M., Toquet, C., Le Gloan, L., Warin-Fresse, K., Guijarro, D., Le Tourneau, T., Conan, E., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12686 · Cited by 72
Poller, W., Haas, J., Klingel, K., Kühnisch, J., Gast, M., Kaya, Z., Escher, F., Kayvanpour, E., Degener, F., Opgen‐Rhein, B., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015289 · Cited by 69
Artico, J., Merlo, M., Delcaro, G., Cannatà, A., Gentile, P., De Angelis, G., Paldino, A., Bussani, R., Ferro, M. D., & Sinagra, G. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.048 · Cited by 65 · cited 1×
“These observations are highly ident lymphocytes and macrophages, which are well documented to be present in myocarditis, including DSP -related myocarditis (51, 52).”
BackgroundGodsel, L. M., Roth‐Carter, Q. R., Koetsier, J. L., Tsoi, L. C., Huffine, A. L., Broussard, J. A., Fitz, G. N., Lloyd, S. M., Kweon, J., Burks, H. E., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci144363 · Cited by 63 · cited 1×
“Cytokines IL-17 and IL-23 are known to contribute to tissue-specific inflammatory pathologies associated with desmosome-related skin disease (55).”
BackgroundSelf-citationIntercalated Discs and Arrhythmogenic Cardiomyopathy
Rampazzo, A., Calore, M., van Hengel, J., & Roy, F. M. V. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.114.000645 · Cited by 61 · cited 1×
“As a structural component of the desmosome, desmoplakin interacts with intermediate filaments, plakoglobin, and plakophi-lin, as well as other elements that directly and indirectly regulate electrical conduction in cardiomyocytes (23, 24).”
BackgroundThe intercalated disc: a unique organelle for electromechanical synchrony in cardiomyocytes
Nielsen, M. S., van Opbergen, C. J. M., van Veen, T. A. B., & Delmar, M. (2023) · Physiological Reviews · doi:10.1152/physrev.00021.2022 · Cited by 56 · cited 1×
“As a structural component of the desmosome, desmoplakin interacts with intermediate filaments, plakoglobin, and plakophi-lin, as well as other elements that directly and indirectly regulate electrical conduction in cardiomyocytes (23, 24).”
BackgroundDesmoplakin Variant-Associated Arrhythmogenic Cardiomyopathy Presenting as Acute Myocarditis
Reichl, K., Kreykes, S. E., Martin, C. M., & Shenoy, C. (2018) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.118.002373 · Cited by 55 · cited 1×
“Similar cardiac inflammation can be visualized in myocarditis patients with DSP gene mutations (11–22).”
BackgroundAder, F., Surget, E., Charron, P., Redheuil, A. B., Zouaghi, A., Maltret, A., Marijon, É., Denjoy, I., Hermida, A., Fressart, V., et al. (2020) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.119.002744 · Cited by 52 · cited 1×
“These observations are highly ident lymphocytes and macrophages, which are well documented to be present in myocarditis, including DSP -related myocarditis (51, 52).”
BackgroundYuan, P., Cheedipudi, S. M., Rouhi, L., Fan, S., Simon, L., Zhao, Z., Hong, K., Gurha, P., & Marian, A. J. (2021) · Circulation · doi:10.1161/circulationaha.120.052928 · Cited by 49 · cited 1×
“Cardiomyocyte-specific Dsp deletion in mice produces cardiac dysfunction, arrhythmias, and fibrosis (31, 32), with activation of apoptosis and increased TGF-β and inflammatory pathways seen in gene expression signatures (33, 34).”
BackgroundCardiostimulatory and antiarrhythmic activity of tubulin-binding agents.
Lampidis, T. J., Kolonias, D. S., Savaraj, N., & Rubin, R. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1256 · Cited by 48
Ng, R., Manring, H. R., Papoutsidakis, N., Albertelli, T., Tsai, N. Y., See, C. J., Li, X., Park, J., Stevens, T. L., Bobbili, P. J., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.128643 · Cited by 44
ZNF416 is a pivotal transcriptional regulator of fibroblast mechanoactivation
Jones, D. L., Meridew, J. A., Link, P. A., Ducharme, M. T., Lydon, K. L., Choi, K. M., Caporarello, N., Tan, Q., Diaz Espinosa, A. M., Xiong, Y., et al. (2021) · Journal of Cell Biology · doi:10.1083/jcb.202007152 · Cited by 41 · cited 1×
“ZNF416 is a zinc finger nuclease associated with fibroblast activation (43), and COUPTFII, encoded by the gene NR2F2 , has been reported to repress glucocorticoid transcriptional activity and alter cardiac metabolism in heart failure (44).”
BackgroundDesmosomal junctions are necessary for adult sinus node function
Mezzano, V., Liang, Y., Wright, A. T., Lyon, R. C., Pfeiffer, E., Song, M. Y., Gu, Y., Dalton, N. D., Scheinman, M., Peterson, K. L., et al. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw083 · Cited by 39 · cited 1×
“Cardiomyocyte-specific Dsp deletion in mice produces cardiac dysfunction, arrhythmias, and fibrosis (31, 32), with activation of apoptosis and increased TGF-β and inflammatory pathways seen in gene expression signatures (33, 34).”
BackgroundPANoptosis is a prominent feature of desmoplakin cardiomyopathy
Olcum, M., Rouhi, L., Fan, S., Gonzales, M. M., Jeong, H.-H., Zhao, Z., Gurha, P., & Marian, A. J. (2022) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2022.34 · Cited by 36 · cited 3×
“TF motif enrichment analysis of differential gene expression in DSP –/– tissues did not identify ZBP1, a master regulator of PANoptosis; however, motifs for other stress markers like C/EBP were observed. er Bio-one, catalog 163290P) according to manufacturer protocols.”
BackgroundHoorntje, E. T., Burns, C., Marsili, L., Corden, B., Parikh, V. N., Meerman, G. J. T., Gray, B. R., Adiyaman, A., Bagnall, R. D., Barge‐Schaapveld, D. Q. C. M., et al. (2022) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.121.003672 · Cited by 34 · cited 1×
“…documented reduced expression of DSP mRNA compared with healthy con-trol hiPSC-CMs, consistent with the heterozygous loss of function in DSP pathological genetic variants (Figure 1B) via nonsense-mediated decay as suggested by a meta-analysis of DSP cardiomyopathic mutations and outcomes (42).”
MethodGeneration of Engineered Human Myocardium in a Multi-well Format
Tiburcy, M., Meyer, T., Liaw, N. Y., & Zimmermann, W. (2020) · STAR Protocols · doi:10.1016/j.xpro.2020.100032 · Cited by 33 · cited 3×
“EHTs are generated by mixing hiPSC-CMs with healthy cardiac fibroblasts at a 9:1 ratio (CMs/cardiac fibroblast) into a fibrin or collagen matrix, then maturing for at least 20 days (35, 36).”
BackgroundMethodBariani, R., Rigato, I., Cason, M., Marinas, M. B., Celeghin, R., Pilichou, K., & Bauce, B. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154313 · Cited by 33
Pérez-Hernández, M., Marrón-Liñares, G. M., Schlamp, F., Heguy, A., van Opbergen, C. J. M., Mezzano, V., Zhang, M., Liang, F.-X., Cerrone, M., & Delmar, M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.623190 · Cited by 32 · cited 1×
“Pérez-Hernández et al. selectively deleted Pkp2 in vivo in mouse cardiomyocytes, demonstrating upregulation of many pathways associated with viral and bacterial infection gene expression (29), similar to some of the pathways we observed in DSP EHTs and rat NRVMs.”
ResultGeorge, S. A., Lin, Z., & Efimov, I. R. (2022) · Communications Biology · doi:10.1038/s42003-022-03279-y · Cited by 32
Self-citationGacita, A. M., Dellefave‐Castillo, L. M., Page, P., Barefield, D. Y., Wasserstrom, J. A., Puckelwartz, M. J., Nóbrega, M. A., & McNally, E. M. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.006926 · Cited by 31 · cited 2×
“RNA-Seq reads were analyzed as previously described (62).”
MethodSelf-citationInterleukin-17 receptor D (Sef) is a multi-functional regulator of cell signaling
Pande, S., Yang, X., & Friesel, R. E. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-020-00695-7 · Cited by 31 · cited 1×
“The downregulation of the IL17RD gene shown in Figure 3B was consistent with a compensatory response to higher levels of the circulating cytokine and increased activation of NF-κ B (45).”
ResultDSP-Related Cardiomyopathy as a Distinct Clinical Entity? Emerging Evidence from an Italian Cohort
Lorenzo, F. D., Marchionni, E., Ferradini, V., Latini, A., Pezzoli, L., Martino, A., Romeo, F., Iorio, A., Bianchi, S., Iascone, M. R., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032490 · Cited by 31
Open-Source Multiparametric Optocardiography
Cathey, B. M., Obaid, S. N., Zolotarev, A. M., Pryamonosov, R. A., Syunyaev, R. A., George, S. A., & Efimov, I. R. (2019) · Scientific Reports · doi:10.1038/s41598-018-36809-y · Cited by 30
Self-citationOllitrault, P., Khoury, M. A., Troadec, Y., Calcagno, Y., Champ‐Rigot, L., Ferchaud, V., Pellissier, A., Legallois, D., Milliez, P., & Labombarda, F. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.998883 · Cited by 29
Management of Recurrent Myocarditis Due to Desmoplakin Cardiomyopathy
Ghawanmeh, M., Frances, B. S., Kerai, A., Patel, P. P., Du, J. J., & Kumar, P. (2022) · JACC Case Reports · doi:10.1016/j.jaccas.2021.10.005 · Cited by 24
Repurposing Colchicine for Heart Disease
Bouabdallaoui, N., & Tardif, J. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-052120-020445 · Cited by 23 · cited 1×
“Colchicine has been shown to be useful in reducing atrial fibrillation after cardiac surgery or catheter ablation and additionally has been shown to reduce adverse cardiac outcomes in other settings (57).”
BackgroundSpatiotemporal cell junction assembly in human iPSC-CM models of arrhythmogenic cardiomyopathy
Kim, S. L., Trembley, M. A., Lee, K. Y., Choi, S., MacQueen, L. A., Zimmerman, J. F., de Wit, L. H. C., Shani, K., Henze, D. E., Drennan, D. J., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.07.005 · Cited by 22
Humanized Dsp ACM Mouse Model Displays Stress-Induced Cardiac Electrical and Structural Phenotypes
Stevens, T. L., Manring, H. R., Wallace, M. J., Argall, A., Dew, T., Papaioannou, P., Antwi-Boasiako, S., Xu, X., Campbell, S. G., Akar, F. G., et al. (2022) · Cells · doi:10.3390/cells11193049 · Cited by 18 · cited 1×
“Ng et al. evaluated DSP R451G and 3 other missense variants and showed an increase in their sensitivity to calpain-mediated degradation (40), and this variant was evaluated in mice (41).”
A case series of desmoplakin cardiomyopathy: a mimic of viral myocarditis
Bookani, K. R., Minga, I., Wodskow, J., Harris, J., Gordon, R. A., Sarswat, N., & Pursnani, A. K. (2022) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytac341 · Cited by 16
Myocarditis or inherited disease? – The multifaceted presentation of arrhythmogenic cardiomyopathy
Westphal, D. S., Krafft, H., Biller, R., Klingel, K., Gaa, J., Mueller, C. S., & Martens, E. (2022) · Gene · doi:10.1016/j.gene.2022.146470 · Cited by 13 · cited 1×
“Similar cardiac inflammation can be visualized in myocarditis patients with DSP gene mutations (11–22).”
BackgroundGenetic Testing for Myocarditis
McNally, E. M., & Selgrade, D. F. (2022) · JACC Heart Failure · doi:10.1016/j.jchf.2022.07.003 · Cited by 13
Self-citationSchoonvelde, S. A. C., Hirsch, A., Yap, S., Verhagen, J. M. A., van Slegtenhorst, M. A., Segers, D., van Loon, J. E., & Michels, M. (2022) · Netherlands Heart Journal · doi:10.1007/s12471-022-01735-2 · Cited by 10
Mechanisms of Innate Immune Injury in Arrhythmogenic CardiomyopathyPreprint
Chelko, S. P., Penna, V. R., Engel, M., Landim-Vieira, M., Cannon, E. N., Lavine, K. J., & Saffitz, J. E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.12.548682 · Cited by 7 · cited 1×
“We tested the NF-κ B inhibitor BAY 11-7082 since this has been shown to be useful in a mouse Dsg2 model of arrhythmogenic cardiomyopathy (27, 28), and we found that this agent improved the depressed contractility in DSP EHTs.”
MethodWarnecke, N., Ulmer, B. M., Laufer, S. D., Shibamiya, A., Krämer, E., Neuber, C., Hanke, S., Behrens, C. S., Loos, M., Münch, J., et al. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102489 · Cited by 6 · cited 1×
“Successful reprogramming was assessed via cell morphology, ability to differentiate, and purity as measured with SSEA3 staining (BD, catalog 560879) via flow cytometry (63).”
MethodFulminant Myocarditis Unmasking Adult-Onset Still’s Disease and Desmoplakin Truncation
Catapano, D., Tontodonato, M., D’Elia, S., Pezzullo, E., Ciaramella, F., Vettori, S., Bussani, R., Ciucci, G., Collesi, C., Sinagra, G., et al. (2023) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.122.015001 · Cited by 6
Chen, V., Knight, B. P., & McNally, E. M. (2022) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytac105 · Cited by 4 · cited 1×
“She was identified as having a pathogenic heterozygous DSP truncation, p.R1951X, which was identified by cascade testing because her first-degree relative presented with myocarditis and ventricular tachycardia, as previously described (14).”
BackgroundSelf-citationMorcos, G. S., Vashist, S., & Aktay, R. (2023) · Radiology Cardiothoracic Imaging · doi:10.1148/ryct.220209 · Cited by 1
Research works printed but not linked: 1
- McNally E, et al. Arrhythmogenic Right Ventricular Cardiomyopathy Overview. In: Adam MP, et al., eds. GeneReviews. University of Washington; April 18, 2005. 20301310
Cited by
Advances in the study and treatment of genetic cardiomyopathies
Parikh, V. N., Day, S. M., Lakdawala, N. K., Adler, E., Olivotto, I., Seidman, C. E., & Ho, C. Y. (2025) · Cell · doi:10.1016/j.cell.2025.01.011 · Cited by 51
Simultaneous electromechanical monitoring in engineered heart tissues using a mesoscale framework
Fullenkamp, D. E., Maeng, W., Oh, S., Luan, H., Kim, K. S., Chychula, I. A., Kim, J., Yoo, J., Holgren, C. W., Demonbreun, A. R., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado7089 · Cited by 44
Self-citationGasperetti, A., Muller, S. A., Peretto, G., Asatryan, B., Protonotarios, A., Laredo, M., Tarlet, P.-Y., Syrris, P., Carrick, R. T., Murray, B., et al. (2025) · Circulation · doi:10.1161/circulationaha.125.073919 · Cited by 36
Desmoplakin Cardiomyopathy: Role of Inflammation and Potential Role of Disease-Modifying Therapies
Gasperetti, A., Carrick, R. T., Muller, S. A., Murray, B. A., Adamo, L., Bauce, B., McNally, E. M., & Helms, A. S. (2025) · Current Cardiology Reports · doi:10.1007/s11886-024-02183-7 · Cited by 13
“In both studies, iPSC-CMs were used to generate heart tissues, and when these tissues were exposed to excess tension, dysfunction of the tissues developed [21, 33].”
Self-citationMaihemuti, N., Shi, Y., Zhang, K., Jiang, X., Chu, J., Xu, Y., Xu, Z., & Wang, K. (2025) · MedComm · doi:10.1002/mco2.70308 · Cited by 12
“Desmosome knockout cell lines exhibit heightened sensitivity to TLRs–NF-κ B signaling, and this response has shown to be remedied by NF-κ B inhibitors, establishing desmosomes as novel regulators of TLR signaling [241].”
Metadata
- Authors
- Selgrade, D. F., Fullenkamp, D. E., Chychula, I. A., Li, B., Dellefave-Castillo, L., Dubash, A. D., Ohiri, J., Monroe, T. O., Blancard, M., Tomar, G., Holgren, C., Burridge, P. W., George, A. L., Demonbreun, A. R., Puckelwartz, M. J., George, S. A., Efimov, I. R., Green, K. J., & McNally, E. M.
- Affiliations
- Center for Genetic Medicine and
- Northwestern University (US)
- Furman University (US)
- Department of Pharmacology,
- Corresponding author
- McNally, Elizabeth M.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2024-05-16
- Volume
- 134
- Issue
- 13
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC11213508
- OpenAlex
- W4398143267
- Cited by
- 30
- References
- 72
- Citations by year
- 2026: 12 · 2025: 16 · 2024: 2
- FWCI
- 8.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- NIH (NIH HL128075 (EMM),NIH HL167813,NIH HL162454 (DFS),NIH HL163392 (DEF),NIH AR43380 (KJG),NIH HL134633 (DFS),Leducq TransAtlantic Foundation (DEF,EMM),International Institute for Nanotechnology Northwestern University (DFS),Chicago Biomedical Consortium PDR)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- desmoplakin, desmosomal proteins, innate immune activation, engineered heart tissue, hiPSC-derived cardiomyocytes, cytokine production, contractile dysfunction, NF-κB inhibition, colchicine, adenine base editing, gene correction, truncating mutations
- MeSH terms
- Female, Humans, Immunity, Innate, Male, Myocarditis, Genetic Predisposition to Disease, Myocytes, Cardiac, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.